About Prellis Biologics
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease, and ADME/Tox models.
Open positions (4)
Company details
Funding
Total raised
$70.1M
Last stage
Series C
Investors
Founders
Melanie Matheu
Dr. Matheu co-founded Prellis Biologics in 2016. An expert in laser-based imaging of the immune system, she developed the company's core platform technology using her PhD work in laser microscopy, cell biology, and biophysics. She previously served as CEO before transitioning to CTO.
LinkedInNoelle Huskey Mullin
Co-founded Prellis Biologics in 2016 alongside Dr. Melanie Matheu.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.